Acta Veterinaria et Zootechnica Sinica ›› 2025, Vol. 56 ›› Issue (9): 4581-4592.doi: 10.11843/j.issn.0366-6964.2025.09.036

• Preventive Veterinary Medicine • Previous Articles     Next Articles

Study on the Expression of Recombinant Limosilactobacillus reuteri Expressing the S1 Gene of Porcine Epidemic Diarrhea Virus to Induce Specific Immune Responses in Piglets

GUO Guihai1(), MA Rumeng1, YIN Fangjie1, LIU Xinzi1, WANG Zi3, MENG Weijing4, LI Jiaxuan1,2, CUI Wen1,2, JIANG Yanping1,2, TANG Lijie1,2, ZHAO Haiyuan1,2,*(), WANG Xiaona1,2,*()   

  1. 1. College of Veterinary Medicines, Northeast Agricultural University, Harbin 150030, China
    2. Provincial Key Laboratory of Animal Disease Prevention and Control Technology and Preparation Development, Harbin 150030, China
    3. Tongliao Institute of Animal Husbandry and Veterinary Science, Tongliao 028000, China
    4. Tongliao Agricultural and Animal Husbandry Development Center, Tongliao 028000, China
  • Received:2024-11-18 Online:2025-09-23 Published:2025-09-30
  • Contact: ZHAO Haiyuan, WANG Xiaona E-mail:ggh2646859744@163.com;zhywxn1925@163.com;xiaonawang0319@163.com

Abstract:

The aim of this study was to express the protective antigen S1 of porcine epidemic diarrhea virus (PEDV) using porcine Limosilactobacillus reuteri as a live bacterial vector, and to evaluate the immune effect after oral immunization of newborn piglets, in order to develop a safe and efficient oral mucosal vaccine preparation. In this study, the recombinant lactic acid strain pPG-T7g10-S1/L. ruteri J 31 expressing PEDV S1 was constructed. The growth characteristics, genetic stability of the recombinant plasmid, and adhesion characteristics of IPEC-J2 cells in vitro were evaluated. The results showed that the growth characteristics of the recombinant strain pPG-T7g10-S1/L. ruteri J 31 did not change significantly compared with the parental strain. The plasmid could be inherited stably and had a strong ability to colonize in the jejunum of piglets. After oral immunization of newborn piglets with the recombinant PEDV, the level of mucosa-specific SIgA antibody and serum specific IgG antibody were produced, and both of them had the activity of neutralizing PEDV, and could induce Th1, Th2 and Th17 types of cellular immune responses in piglets. In conclusion, in this study, the recombinant Limosilactobacillus reuteri pPG-T7g10-S1/L. ruteri J 31 was successfully constructed. Oral immunization with the pPG-T7G10-S1/L. ruteri J 31 could induce significant humoral immunity, mucosal immunity and Th1, Th2 and Th17 cellular immune responses in piglets. These results laid a theoretical and experimental foundation for the development of oral PEDV vaccine candidates.

Key words: porcine epidemic diarrhea, Limosilactobacillus reuteri, oral vaccine

CLC Number: